Joseph Rosado
Lake Erie College of Osteopathic Medicine, USA
Keynote: Clinical Neurology & Neurosurgery
Background: Alzheimer's disease (AD) is a progressive and irreversible brain disorder that slowly destroys memory and thinking skills and eventually the ability to carry out the simplest tasks. Currently, it ranks as the sixth leading cause of death in the United States and the fourth leading cause of death on the island of Puerto Rico and Colombia. Medical cannabis is now a part of contemporary medicine, with physicians recommending a medical card in 33 states and two territories in the United States of America, for physiological conditions such as vomiting, migraines, multiple sclerosis, glaucoma, nausea, cell disease sickle cell disease, Parkinson's disease, sleep apnea, spinal cord injury, arthritis, Alzheimer's disease, muscle spasms, and asthma, as well as psychological conditions such as anxiety disorder, insomnia, bipolar disorder, depression, and posttraumatic stress disorder. Design/Methods: A literature review was conducted of the National Center for Biotechnology Information, U.S. National Library of Medicine PubMed from 2001-2019 specific to the topic of Alzheimer’s Disease and Medical Cannabis/Medical Marijuana/CBD/THC. Results: Phytocannabinoid treatment can restore cognition in older animals and induce molecular changes that make them more similar to young animals. Conclusion: The inherent polypharmaceutical properties of cannabis botanicals offer distinct advantages over the current single-target pharmaceutical model and heralds revolutionizing neurological treatment into a new reality of effective and even preventative interventional treatment and studies show that cannabis extracts can be used in safe way to improve symptoms of severe dementia.
After spending several years in central Florida working as an orderly/certified nurse’s aide, then an EMT, a paramedic, and a cardiac catheterization lab technician, Dr. Rosado realized his passion for the medical profession. He began chiropractic school at Life College in Marietta, GA, graduating cum laude with a BS in Clinical Nutrition and a Doctor of Chiropractic. After practicing for several years, he went to the Universidad Central del Este, in San Pedro de Macoris, Dominican Republic, where in 2001 he graduated summa cum laude with his medical degree. In 2005 he completed his master's degree in healthcare management from the University of Phoenix and graduated magna cum laude. In 2018 he became a Diplomate of the American Academy of Cannabinoid Medicine. Upon completion of his medical training, he worked as a physician, clinic and hospital director, director of the division of communicable diseases/epidemiology and immunization departments. Currently, Dr. Rosado is the Medical Director of an integrative medicine clinic in DeLand, FL and a mental health clinic in St. Augustine, FL, Adjunct Professor for Lake Erie College of Osteopathic Medicine, the President and CEO of International Medical Consultants and the Medical Director of Minorities 4 Medical Marijuana. As an advocate, he was and is on the speakers’ bureau for political campaigns and licensed medical cannabis dispensaries/producers in Florida. As a clinician, he has worked with infants, children, adolescents, adults, and geriatric patients for medical cannabis
Journal of Clinical Neurology and Neurosurgery received 2 citations as per Google Scholar report